CBS19 News7h
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Jackson Progress-Argus7h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
KSJB AM8h
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
In 2021, semaglutide was approved by the FDA for chronic weight ... Older adults, especially those 65 and over, also face ...
The Manhattan Mercury9h
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Digital Courier9h
North Carolina Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Iosco County News-Herald9h
Michigan Residents Are Using GLP-1s at the 6th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Southwest Iowa News9h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Stoneham Independent10h
Massachusetts Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
KTEN1d
Texas Has the 10th Lowest Rate of GLP-1 Use in the Nation
In 2021, semaglutide was approved by the FDA for chronic weight management ... Older adults, especially those 65 and over, ...
TiogaPublishing.com1d
Pennsylvania Residents Are Using GLP-1s at the 10th Highest Rate in the Country
In 2021, semaglutide was approved by the FDA for chronic weight management ... Older adults, especially those 65 and over, ...
San Francisco Examiner1d
California Residents Are Using GLP-1s at the 11th Lowest Rate in the Country
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
North Star Monthly1d
Vermont Residents Are Using GLP-1s at an Above Average Rate
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...